103 related articles for article (PubMed ID: 6448615)
21. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits.
Germuth FG; Rodriguez E; Lorelle CA; Trump EI; Milano LL; Wise O
Lab Invest; 1979 Oct; 41(4):366-71. PubMed ID: 158675
[TBL] [Abstract][Full Text] [Related]
22. Effects of dietary linoleic acid enrichment on induction of immune complex nephritis in mice.
Kher V; Barcelli U; Weiss M; Pollak VE
Nephron; 1985; 39(3):261-6. PubMed ID: 3156280
[TBL] [Abstract][Full Text] [Related]
23. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
Collins AL; Song CW
Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
[TBL] [Abstract][Full Text] [Related]
24. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen.
Oite T; Batsford SR; Mihatsch MJ; Takamiya H; Vogt A
J Exp Med; 1982 Feb; 155(2):460-74. PubMed ID: 6460074
[TBL] [Abstract][Full Text] [Related]
25. Complement system promotes transfer of immune complex across glomerular filtration barrier.
Fujigaki Y; Batsford SR; Bitter-Suermann D; Vogt A
Lab Invest; 1995 Jan; 72(1):25-33. PubMed ID: 7837787
[TBL] [Abstract][Full Text] [Related]
26. Experimental glomerulonephritis induced by immune complexes of monoclonal antibodies produced by immunoglobulin class-switch variants.
Chen XM; Tanaka T; Kobayashi Y; Shigematsu H; Okumura K
Lab Invest; 1987 Dec; 57(6):665-72. PubMed ID: 3695412
[TBL] [Abstract][Full Text] [Related]
27. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
28. Systemic toxicity of non-cell corynebacterium parvum (CP) in monkeys.
Li BQ; Dong X; Fang SH; Yang GQ; Gao JY; Zhang JX; Gu FM; Zhao H
J Toxicol Sci; 2010 Jun; 35(3):279-86. PubMed ID: 20519835
[TBL] [Abstract][Full Text] [Related]
29. Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice.
Cavallo T; Granholm NA
Am J Pathol; 1990 Oct; 137(4):971-8. PubMed ID: 2221021
[TBL] [Abstract][Full Text] [Related]
30. Chronic antigen-antibody-complex glomerulonephritis in mice.
Steward MW; Collins MJ; Stanley C; Devey ME
Br J Exp Pathol; 1981 Dec; 62(6):614-22. PubMed ID: 6459798
[TBL] [Abstract][Full Text] [Related]
31. Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype.
Lew AM; Staines NA; Steward MW
Clin Exp Immunol; 1984 Aug; 57(2):413-22. PubMed ID: 6205798
[TBL] [Abstract][Full Text] [Related]
32. Experimental antigen-antibody complex disease in mice. The role of antibody levels, antibody affinity and circulating antigen-antibody complexes.
Devey ME; Bleasdale K; Collins M; Steward MW
Int Arch Allergy Appl Immunol; 1982; 68(1):47-53. PubMed ID: 6210640
[TBL] [Abstract][Full Text] [Related]
33. Experimental glomerulonephritis induced by human IgG in rats.
Yamamoto K; Oite T; Kihara I; Shimizu F
Clin Exp Immunol; 1984 Sep; 57(3):575-82. PubMed ID: 6235995
[TBL] [Abstract][Full Text] [Related]
34. Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes.
Nakazawa M; Emancipator SN; Lamm ME
Lab Invest; 1986 Nov; 55(5):551-6. PubMed ID: 2430139
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of glomerular extracellular matrix and transforming growth factor-beta expression in RF/J mice.
Kamata T; Muso E; Yashiro M; Kawamura T; Oyama A; Matsushima H; Takeuchi E; Yoshida H; Sasayama S
Kidney Int; 1999 Mar; 55(3):864-76. PubMed ID: 10027923
[TBL] [Abstract][Full Text] [Related]
36. Thiamphenicol and lupus nephritis. The effects of long-term therapy on kidney function and pathology: a pilot study.
Simpson LO; Aarons I; Howie JB
Br J Exp Pathol; 1979 Feb; 60(1):45-57. PubMed ID: 157149
[TBL] [Abstract][Full Text] [Related]
37. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
38. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of circulating immune complexes in children with glomerulonephritis].
Konstantinova NA; Sitnikova VP; Nastausheva TL
Pediatriia; 1989; (5):15-8. PubMed ID: 2528115
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes in rats with autologous immune complex nephritis.
Abrass CK; Border WA; Glassock RJ
Lab Invest; 1980 Jul; 43(1):18-27. PubMed ID: 6446622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
